×
ADVERTISEMENT

MARCH 29, 2017

Are We There Yet? Basing Payment on the Clinical Activity of a Novel Antineoplastic


Cancer Treatment Centers of America
Drexel University College of Medicine
Philadelphia, Pennsylvania

“Are we there yet?” This is a question parents have likely been asked by their young children, nearing the end of a long car ride to visit a relative. This simple inquiry also can be appropriately addressed to a much larger audience regarding whether we as a society have finally arrived closer to the point where we will no longer tolerate the irrational cost of beneficial pharmaceutical